Dr. Carolyn M. Mulroney
Claim this profileUC San Diego Moores Cancer Center
Studies Lymphoma
Studies Non-Hodgkin's Lymphoma
8 reported clinical trials
15 drugs studied
Affiliated Hospitals
Clinical Trials Carolyn M. Mulroney is currently running
Tabelecleucel
for Post-Transplant Cancer
The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) after failure of rituximab (SOT-R) and rituximab plus chemotherapy (SOT-R+C) or (2) allogeneic hematopoietic cell transplant (HCT) after failure of rituximab.
Recruiting2 awards Phase 312 criteria
Tuspetinib
for Acute Myeloid Leukemia
The main purpose of this study is to identify a safe and potentially effective dose of tuspetinib to be used in future studies in study participants diagnosed with acute myeloid leukemia (AML), myelodysplastic syndromes with increased blasts grade 2 (MDS-IB2), or chronic myelomonocytic leukemia (CMML) that is relapsed or refractory after at least one line of prior therapy, or in study participants with newly diagnosed AML. Tuspetinib will be administered as a single agent or in combination with other drugs (venetoclax or venetoclax plus azacitidine), as specified for each part of the study.
Recruiting1 award Phase 1 & 222 criteria
More about Carolyn M. Mulroney
Clinical Trial Related7 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Carolyn M. Mulroney has experience with
- CLBR001
- Rituximab
- SWI019
- Placebo
- Autologous Hematopoietic Cell Transplantation
- Standard Preventive And Supportive Care Therapies
Breakdown of trials Carolyn M. Mulroney has run
Lymphoma
Non-Hodgkin's Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Carolyn M. Mulroney specialize in?
Carolyn M. Mulroney focuses on Lymphoma and Non-Hodgkin's Lymphoma. In particular, much of their work with Lymphoma has involved CD19 positive patients, or patients who are undergoing treatment.
Is Carolyn M. Mulroney currently recruiting for clinical trials?
Yes, Carolyn M. Mulroney is currently recruiting for 2 clinical trials in San Diego California. If you're interested in participating, you should apply.
Are there any treatments that Carolyn M. Mulroney has studied deeply?
Yes, Carolyn M. Mulroney has studied treatments such as CLBR001, Rituximab, SWI019.
What is the best way to schedule an appointment with Carolyn M. Mulroney?
Apply for one of the trials that Carolyn M. Mulroney is conducting.
What is the office address of Carolyn M. Mulroney?
The office of Carolyn M. Mulroney is located at: UC San Diego Moores Cancer Center, San Diego, California 92093 United States. This is the address for their practice at the UC San Diego Moores Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.